Janus Henderson Group PLC Bridge Bio Pharma, Inc. Transaction History

Janus Henderson Group PLC

$178 Billion
Q1 2024

A detailed history of Janus Henderson Group PLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,312,706 shares of BBIO stock, worth $83.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,312,706

Previous 1,143,563 189.68%

Holding current value

$83.9 Million

Previous $46.2 Million 121.87%

% of portfolio

0.06%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $59.3 Million - $87.7 Million	2,169,143 Added 189.68%	3,312,706 $102 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $1,201 - $2,194	-50 Reduced -0.0%	1,143,563 $46.2 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $18.6 Million - $38.5 Million	1,100,120 Added 2529.42%	1,143,613 $30.2 Million
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $810,357 - $1.1 Million	-60,975 Reduced 58.37%	43,493 $748,000
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $649,888 - $1.68 Million	90,640 Added 655.48%	104,468 $1.73 Million

Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $6 - $11	-1 Reduced 0.01%	13,828 $105,000
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $1,881 - $2,929	-237 Reduced 1.68%	13,829 $137,000
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $1,135 - $2,646	218 Added 1.57%	14,066 $128,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $102 - $240	-14 Reduced 0.1%	13,848 $141,000
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $29.9 Million - $141 Million	-2,631,579 Reduced 99.48%	13,862 $231,000
Q3 2021 Nov 16, 2021	SELL	$46.87 - $64.24 $7.74 Million - $10.6 Million	-165,211 Reduced 5.88%	2,645,441 $124 Million
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $2.91 Million - $4 Million	-62,531 Reduced 2.18%	2,810,652 $171 Million
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $60.4 Million - $78.8 Million	1,089,648 Added 61.09%	2,873,183 $177 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $3.53 Million - $6.55 Million	92,074 Added 5.44%	1,783,535 $127 Million
Q3 2020 Nov 16, 2020	SELL	$27.2 - $42.19 $2.02 Million - $3.14 Million	-74,403 Reduced 4.21%	1,691,461 $63.5 Million
Q2 2020 Aug 14, 2020	SELL	$22.22 - $35.69 $448,288 - $720,045	-20,175 Reduced 1.13%	1,765,864 $57.6 Million
Q1 2020 May 14, 2020	SELL	$16.11 - $36.23 $21.8 Million - $49.1 Million	-1,355,042 Reduced 43.14%	1,786,039 $51.8 Million
Q4 2019 Feb 18, 2020	BUY	$17.96 - $46.63 $48.3 Million - $125 Million	2,688,910 Added 594.67%	3,141,081 $110 Million
Q3 2019 Nov 14, 2019	BUY	$20.13 - $32.38 $2.14 Million - $3.44 Million	106,182 Added 30.69%	452,171 $9.71 Million
Q2 2019 Jul 31, 2019	BUY	$26.97 - $27.55 $9.33 Million - $9.53 Million	345,989 New	345,989 $9.33 Million

Others Institutions Holding BBIO

# of Institutions

284

Shares Held

170M

Call Options Held

7.41M

Put Options Held

2.61M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.76B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Bridge Bio Pharma, Inc. Transaction History